Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.900
+0.031 (3.51%)
At close: Nov 20, 2024, 4:00 PM
0.920
+0.020 (2.22%)
After-hours: Nov 20, 2024, 7:15 PM EST

Hyperfine Revenue

Hyperfine had revenue of $3.64M in the quarter ending September 30, 2024, with 56.35% growth. This brings the company's revenue in the last twelve months to $13.26M, up 35.67% year-over-year. In the year 2023, Hyperfine had annual revenue of $11.03M with 61.90% growth.

Revenue (ttm)
$13.26M
Revenue Growth
+35.67%
P/S Ratio
4.90
Revenue / Employee
$101,183
Employees
131
Market Cap
65.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.03M4.22M61.90%
Dec 31, 20226.81M5.32M355.48%
Dec 31, 20211.50M1.20M408.84%
Dec 31, 2020294.00K--
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 113.86M
Spero Therapeutics 106.46M
Atara Biotherapeutics 100.44M
Metagenomi 55.08M
Champions Oncology 51.66M
Celularity 42.69M
X4 Pharmaceuticals 1.12M
Monogram Technologies 365.00K
Revenue Rankings